Sunovion acquires CYNA for $40.50/sh in cash—a 121% premium to today’s closing price: http://finance.yahoo.com/news/sunovion-pharmaceuticals-acquire-cynapsus-therapeutics-210700872.html The nominal deal value is $624M. Sunovion is the US subsidiary of Japan’s Sumitomo Dainippon Pharma (#msg-41143301).